The gene-editing technique known as CRISPR is promising to revolutionize medicine. Some researchers are trying to help make it available for people with very rare genetic disorders.
A federally approved test for melioidosis, a potentially deadly bacterial infection, doesn't currently exist. But a Seattle company plans to fill this gap.